Resmed Inc. buy JPMorgan Chase & Co.
Start price
31.01.25
/
50%
€233.00
Target price
31.01.26
€274.39
Performance (%)
-10.98%
Price
18.12.25
€206.90
Summary
This prediction is currently active. The prediction for Resmed Inc. disappoints with a performance of -10.98%. A total of €0.51 was paid as dividends for this prediction. This prediction currently runs until 31.01.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | -3.767% | -3.767% |
| iShares Core DAX® | -0.793% | 4.201% |
| iShares Nasdaq 100 | -2.376% | 0.857% |
| iShares Nikkei 225® | -2.701% | -0.147% |
| iShares S&P 500 | -1.689% | 1.244% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at JPMorgan Chase & Co. from $270.00 to $286.00. They now have an "overweight" rating on the stock.
Ratings data for RMD provided by MarketBeat